Neurophysiological Effects of Bitopertin in Schizophrenia

Item

http://www.wikidata.org/entity/Q57828993

description

im August 2017 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 01 August 2017

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2017

@uk

name

Neurophysiological Effects of Bitopertin in Schizophrenia

@en

Neurophysiological Effects of Bitopertin in Schizophrenia

@nl

type

Item

label

Neurophysiological Effects of Bitopertin in Schizophrenia

@en

Neurophysiological Effects of Bitopertin in Schizophrenia

@nl

prefLabel

Neurophysiological Effects of Bitopertin in Schizophrenia

@en

Neurophysiological Effects of Bitopertin in Schizophrenia

@nl

P1476

Neurophysiological Effects of Bitopertin in Schizophrenia

@en

P2093

Constance Shope

http://www.w3.org/2001/XMLSchema#string

Daniel C Javitt

http://www.w3.org/2001/XMLSchema#string

Joshua T Kantrowitz

http://www.w3.org/2001/XMLSchema#string

Karen A Nolan

http://www.w3.org/2001/XMLSchema#string

Nayla Lehrfeld

http://www.w3.org/2001/XMLSchema#string

P2860

Auditory dysfunction in schizophrenia: integrating clinical and basic features.

A multicenter, add-on randomized controlled trial of low-dose d-serine for negative and cognitive symptoms of schizophrenia

Characterization of neurophysiologic and neurocognitive biomarkers for use in genomic and clinical outcome studies of schizophrenia

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

Recent advances in the phencyclidine model of schizophrenia

A Meta-Analysis of Mismatch Negativity in Schizophrenia: From Clinical Risk to Disease Specificity and Progression

Neural Substrates of Auditory Emotion Recognition Deficits in Schizophrenia.

Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2.

Differential relationships of mismatch negativity and visual p1 deficits to premorbid characteristics and functional outcome in schizophrenia.

N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia?

P304

447-451

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/JCP.0000000000000722

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eva Petkova

Michael L. Epstein

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28590364

http://www.w3.org/2001/XMLSchema#string

P921

schizophrenia

neurophysiology

P932

5492956

http://www.w3.org/2001/XMLSchema#string